BioCentury
ARTICLE | Company News

Nautilus Neurosciences Inc., Kowa sales and marketing update

June 14, 2010 7:00 AM UTC

Nautilus launched oral Cambia diclofenac powder in the U.S. to treat acute migraine attacks with or without aura. The wholesale acquisition cost (WAC) of the product is $171.90 for a box of nine dose...